Our permeation technology we refer to as “decoys”, is available for license in numerous commercial applications including human, animal and agriculture. The nature of our decoys minimizes development and regulatory risks and significantly reduces the time to market with existing active agents.
Our Decoys technology can significantly enhance tissue concentrations of active agents and provide an opportunity for an oral to topical or prescription to OTC switches. Decoys can be easily combined with existing formulations, enjoy a low regulatory hurdle (in most cases), improve the safety profile of active agents, provide a significant competitive barrier and extend the commercial value of older active agents.
Formulation & application
Our Decoys typically represent less than 1% of the final formulation and can be diversely utilized. Formulation options include gels, ointments, lotions, emulsions, pastes, creams, foams, mousses, liquids/solutions, suspensions or powders. There are a diverse number of application methods including topicals in the form of a leave-on or apply and wipe, patch, spray/aerosol or in combination with other topical applicator technologies.
Making life safer
Our Decoy technology reduces the quantity of potentially harmful active agents necessary to achieve a desired objective. Our novel and physiological approach delivers active agents safely between cells and avoids damaging cells or cell junctions. Therefore, the size of the payload active agent is not limited by the size of the cell. Larger molecules can penetrate tissues and smaller molecules are delivered much more efficiently.